{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:51Z","timestamp":1707524211114},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,30]]},"DOI":"10.7759\/cureus.15327","type":"journal-article","created":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T09:01:21Z","timestamp":1622365281000},"source":"Crossref","is-referenced-by-count":0,"title":["Antiretroviral Tenofovir Induces Senescence-Associated \u03b2-Galactosidase Activity in Primary Human Brain Vascular Cells in Multi-Layer Three-Dimensional Co-Culture"],"prefix":"10.7759","author":[{"given":"Rachel C","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benchawanna","family":"Soontornniyomkij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anya","family":"Umlauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virawudh","family":"Soontornniyomkij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Antiretroviral Therapy Cohort Collaboration","year":"2017","unstructured":"Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017, 4:349-356. 10.1016\/S2352-3018(17)30066-8","journal-title":"Lancet HIV"},{"key":"ref2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. (2019). Accessed: December 18, 2019: http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2007.01.007","article-title":"Management of antiretroviral treatment-related complications","volume":"21","author":"Hoffman RM","year":"2007","unstructured":"Hoffman RM, Currier JS. Management of antiretroviral treatment-related complications. Infect Dis Clin North Am. 2007, 21:103-132. 10.1016\/j.idc.2007.01.007","journal-title":"Infect Dis Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1310\/hct1001-001","article-title":"Effects of first-line use of nucleoside analogues, efavirenz, and ritonavir-boosted protease inhibitors on lipid levels","volume":"10","author":"Hill A","year":"2009","unstructured":"Hill A, Sawyer W, Gazzard B. Effects of first-line use of nucleoside analogues, efavirenz, and ritonavir-boosted protease inhibitors on lipid levels. HIV Clin Trials. 2009, 10:1-12. 10.1310\/hct1001-001","journal-title":"HIV Clin Trials"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli N","year":"2011","unstructured":"Ciccarelli N, Fabbiani M, Di Giambenedetto S, et al.. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011, 76:1403-1409. 10.1212\/WNL.0b013e31821670fb","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-015-0382-7","article-title":"Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients","volume":"22","author":"Ma Q","year":"2016","unstructured":"Ma Q, Vaida F, Wong J, et al.. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016, 22:170-178. 10.1007\/s13365-015-0382-7","journal-title":"J Neurovirol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000262","article-title":"HIV protease inhibitor exposure predicts cerebral small vessel disease","volume":"28","author":"Soontornniyomkij V","year":"2014","unstructured":"Soontornniyomkij V, Umlauf A, Chung SA, et al.. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014, 28:1297-1306. 10.1097\/QAD.0000000000000262","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000027","article-title":"HCV, but not HIV, is a risk factor for cerebral small vessel disease","volume":"1","author":"Morgello S","year":"2014","unstructured":"Morgello S, Murray J, Van Der Elst S, Byrd D. HCV, but not HIV, is a risk factor for cerebral small vessel disease. Neurol Neuroimmunol Neuroinflamm. 2014, 1:27. 10.1212\/NXI.0000000000000027","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2015.62","article-title":"Perturbations of the cerebrovascular matrisome: a convergent mechanism in small vessel disease of the brain?","volume":"36","author":"Joutel A","year":"2016","unstructured":"Joutel A, Haddad I, Ratelade J, Nelson MT. Perturbations of the cerebrovascular matrisome: a convergent mechanism in small vessel disease of the brain?. J Cereb Blood Flow Metab. 2016, 36:143-157. 10.1038\/jcbfm.2015.62","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X15606723","article-title":"Cerebral small vessel disease: capillary pathways to stroke and cognitive decline","volume":"36","author":"Ostergaard L","year":"2016","unstructured":"Ostergaard L, Engedal TS, Moreton F, et al.. Cerebral small vessel disease: capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab. 2016, 36:302-325. 10.1177\/0271678X15606723","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref11","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni L","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010, 9:689-701. pii] 10.1016\/S1474-4422(10)70104-6","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001927","article-title":"Association of antiretroviral therapy with brain aging changes among HIV-infected adults","volume":"32","author":"Soontornniyomkij V","year":"2018","unstructured":"Soontornniyomkij V, Umlauf A, Soontornniyomkij B, et al.. Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018, 32:2005-2015. 10.1097\/QAD.0000000000001927","journal-title":"AIDS"},{"key":"ref13","unstructured":"Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 update. A clinical practice guideline. (2018). https.\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri GP","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, et al.. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995, 92:9363-9367. 10.1073\/pnas.92.20.9363","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.191","article-title":"Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo","volume":"4","author":"Debacq-Chainiaux F","year":"2009","unstructured":"Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009, 4:1798-1806. 10.1038\/nprot.2009.191","journal-title":"Nat Protoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-239-1_9","article-title":"Chemiluminescent detection of senescence-associated beta galactosidase","volume":"965","author":"Bassaneze V","year":"2013","unstructured":"Bassaneze V, Miyakawa AA, Krieger JE. Chemiluminescent detection of senescence-associated beta galactosidase. Methods Mol Biol. 2013, 965:157-163. 10.1007\/978-1-62703-239-1_9","journal-title":"Methods Mol Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.213603","article-title":"Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin","volume":"30","author":"Lef\u00e8vre C","year":"2010","unstructured":"Lef\u00e8vre C, Auclair M, Boccara F, Bastard JP, Capeau J, Vigouroux C, Caron-Debarle M. Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin. Arterioscler Thromb Vasc Biol. 2010, 30:2611-2620. 10.1161\/ATVBAHA.110.213603","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-201X.2004.01383.x","article-title":"Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors","volume":"183","author":"Rudich A","year":"2005","unstructured":"Rudich A, Ben-Romano R, Etzion S, Bashan N. Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors. Acta Physiol Scand. 2005, 183:75-88. 10.1111\/j.1365-201X.2004.01383.x","journal-title":"Acta Physiol Scand"},{"key":"ref19","article-title":"Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones","volume":"13","author":"Mondal D","year":"2013","unstructured":"Mondal D, Liu K, Hamblin M, Lasky JA, Agrawal KC. Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones. Ochsner J. 2013, 13:76-90.","journal-title":"Ochsner J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1385\/ct:4:2:117","article-title":"Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation","volume":"4","author":"Hebert VY","year":"2004","unstructured":"Hebert VY, Crenshaw BL, Romanoff RL, Ekshyyan VP, Dugas TR. Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation. Cardiovasc Toxicol. 2004, 4:117-131. 10.1385\/ct:4:2:117","journal-title":"Cardiovasc Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/30482-antiretroviral-tenofovir-induces-senescence-associated--galactosidase-activity-in-primary-human-brain-vascular-cells-in-multi-layer-three-dimensional-co-culture","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:32Z","timestamp":1707506672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/30482-antiretroviral-tenofovir-induces-senescence-associated--galactosidase-activity-in-primary-human-brain-vascular-cells-in-multi-layer-three-dimensional-co-culture"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.15327","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,30]]}}}